ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wewel, A. R.
Right arrow Articles by Holz, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wewel, A. R.
Right arrow Articles by Holz, O.
Eur Respir J 2006; 27:1033-1039
Copyright ©ERS Journals Ltd 2006

Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy

A. R. Wewel1, J. A. M. Crusius1, U. Gatzemeier1, M. Heckmayr1, G. Becher2, H. Magnussen1, R. A. Jörres1,3 and O. Holz1,4

1 Hospital Großhansdorf, Center for Pneumology and Thoracic Surgery, Großhansdorf, 2 FILT, Berlin, 3 Institute and Outpatient Clinic for Occupational and Environmental Medicine, Ludwig-Maximilians University, Munich, and 4 University of Lüneburg, Environmental Chemistry, Lüneburg, Germany.

CORRESPONDENCE: O. Holz, Research Laboratory, Hospital Großhansdorf, Center for Pneumology and Thoracic Surgery, Wöhrendamm 80, D-22927 Großhansdorf, Germany. Fax: 49 4102692295. E-mail: o.holz{at}pulmoresearch.de

Keywords: Carboplatin, cisplatin, exhaled breath condensate, neutrophils, peripheral blood

Received: September 1, 2005
Accepted December 23, 2005

This study was designed to assess the effect of differential leukocyte depletion during chemotherapy by monitoring the levels of exhaled hydrogen peroxide H2O2 and nitric oxide (FeNO) present.

In 39 patients with lung cancer (chronic obstructive pulmonary disorder up to stage II, median forced expiratory volume in one second 78% predicted), measurements were performed before a cycle of therapy (day 1), at least once during the cycle (day 8: n = 34; day 15: n = 19), and afterwards (days 21–29).

There were significant changes in the level of H2O2, FeNO and peripheral blood cell differentials over the visits. The level of H2O2 was decreased only on day 15, with a median (difference between the upper and lower quartiles) fall of 31 (57)%, while FeNO was reduced only on day 8, by 22 (40)%. Neutrophil numbers were unchanged on day 8 and decreased by 59 (48)% on day 15, while monocyte numbers were decreased on day 8 by 87 (39)%. On days 21–29, values had returned to baseline.

Taken together with previous findings, the parallel course of levels of exhaled hydrogen peroxide and neutrophil counts suggests that a major part of exhaled hydrogen peroxide is due to neutrophils via the conducting airways. In contrast, the production of exhaled nitric oxide seems to be primarily associated with monocytes.




This article has been cited by other articles:


Home page
Eur Respir JHome page
I. Horvath, Z. Lazar, N. Gyulai, M. Kollai, and G. Losonczy
Exhaled biomarkers in lung cancer
Eur. Respir. J., July 1, 2009; 34(1): 261 - 275.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.